Complications of Viral Influenza

American Journal of Medicine

Volumn 121, Issue 4, 2008, Pages 258-264

  Rothberg, Michael B ^a,b   Haessler, Sarah D ^a,b   Brown, Richard B ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral therapy; Complications; Influenza; Pneumonia; Vaccination

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

BACTERIAL INFECTION; COMORBIDITY; HEART DISEASE; HIGH RISK PATIENT; HUMAN; INFECTION COMPLICATION; INFLUENZA; INFLUENZA VIRUS; LUNG COMPLICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NEUROMUSCULAR FUNCTION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SECONDARY INFECTION; VACCINATION;

AGE DISTRIBUTION; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; ORTHOMYXOVIRIDAE; PNEUMONIA, VIRAL; PREGNANCY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SUPERINFECTION; SURVIVAL ANALYSIS; UNITED STATES; VACCINATION;

EID: 40949156150     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.10.040     Document Type: Review

References (87)

1. Thompson W.W., Shay D.K., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
2. Thompson W.W., Shay D.K., Weintraub E., et al. Influenza-associated hospitalizations in the United States. JAMA 292 (2004) 1333-1340
3. Simonsen L., Taylor R., Viboud C., et al. US flu mortality estimates are based on solid science. BMJ 332 (2006) 177-178
4. Simonsen L., Reichert T.A., Viboud C., et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165 (2005) 265-272
5. Dushoff J., Plotkin J.B., Viboud C., et al. Mortality due to influenza in the United States-an annualized regression approach using multiple-cause mortality data. Am J Epidemiol 163 (2006) 181-187
6. Rothberg M. Prioritizing influenza vaccination. JAMA 292 (2004) 2582-2583
7. Glezen W.P., Decker M., and Perrotta D.M. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis 136 (1987) 550-555
8. Izurieta H.S., Thompson W.W., Kramarz P., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342 (2000) 232-239
9. Smith N.M., Bresee J.S., Shay D.K., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 (2006) 1-42
10. Hak E., Wei F., Nordin J., et al. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 189 (2004) 450-458
11. Neuzil K.M., Reed G.W., Mitchel E.F., et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 148 (1998) 1094-1102
12. Schrag S.J., Fiore A.E., Gonik B., et al. Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol 101 (2003) 704-710
13. Influenza vaccination in pregnancy: practices among obstetrician-gynecologists-United States, 2003-04 influenza season. MMWR Morb Mortal Wkly Rep 54 (2005) 1050-1052
14. Skiest D.J., Kaplan P., Machala T., et al. Clinical manifestations of influenza in HIV-infected individuals. Int J STD AIDS 12 (2001) 646-650
15. Klein M.B., Lu Y., DelBalso L., et al. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis 45 (2007) 234-240
16. Neuzil K.M., Reed G.W., Mitchel Jr. E.F., and Griffin M.R. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 281 (1999) 901-907
17. Fine A.D., Bridges C.B., De Guzman A.M., et al. Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. Clin Infect Dis 32 (2001) 1784-1791
18. Lin J.C., and Nichol K.L. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 161 (2001) 441-446
19. Golden M.P., Sajjad Z., and Elgart L. Influenza and human immunodeficiency virus infection: absence of HIV progression after acute influenza infection. Clin Infect Dis 32 (2001) 1366-1370
20. Whimbey E., Champlin R.E., Couch R.B., et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 22 (1996) 778-782
21. Vilchez R.A., McCurry K., Dauber J., et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2 (2002) 287-291
22. Louria D.B., Blumenfeld H.L., Ellis J.T., et al. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 38 (1959) 213-265
23. Murata Y., Walsh E.E., and Falsey A.R. Pulmonary complications of interpandemic influenza A in hospitalized adults. J Infect Dis 195 (2007) 1029-1037
24. Oliveira E.C., Marik P.E., and Colice G. Influenza pneumonia: a descriptive study. Chest 119 (2001) 1717-1723
25. Noble R.L., Lillington G.A., and Kempson R.L. Fatal diffuse influenzal pneumonia: premortem diagnosis by lung biopsy. Chest 63 (1973) 644-646
26. Peiris J.S., de Jong M.D., and Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 20 (2007) 243-267
27. The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. N Engl J Med 353 (2005) 1374-1385
28. Treanor J. Influenza virus. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases. 6th ed. 162 vol. (2005), Churchill Livingstone, Philadelphia 2060-2085
29. Schwarzmann S.W., Adler J.L., Sullivan Jr. R.J., and Marine W.M. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med 127 (1971) 1037-1041
30. Chickering H., and Park J.H. Staphylococcus aureus pneumonia. JAMA 72 (1919) 617-626
31. Prechter G.C., and Gerhard A.K. Postinfluenza toxic shock syndrome. Chest 95 (1989) 1153-1154
32. Hageman J.C., Uyeki T.M., Francis J.S., et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 12 (2006) 894-899
33. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 56 (2007) 325-329
34. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19 (2006) 571-582
35. Lewis M., Kallenbach J., Ruff P., et al. Invasive pulmonary aspergillosis complicating influenza A pneumonia in a previously healthy patient. Chest 87 (1985) 691-693
36. Boots R.J., Paterson D.L., Allworth A.M., and Faoagali J.L. Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. Thorax 54 (1999) 1047-1049
37. Miyashita N., and Matsushima T. Chlamydia pneumoniae infection during an influenza virus A epidemic: preliminary report. J Med Microbiol 49 (2000) 391-392
38. Gerber G.J., Farmer W.C., and Fulkerson L.L. Beta-hemolytic streptococcal pneumonia following influenza. JAMA 240 (1978) 242-243
39. Garantziotis S., Howell D.N., McAdams H.P., et al. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest 119 (2001) 1277-1280
40. Pinsker K.L., Schneyer B., Becker N., and Kamholz S.L. Usual interstitial pneumonia following Texas A2 influenza infection. Chest 80 (1981) 123-126
41. Wilson C.B., and Smith R.C. Goodpasture's syndrome associated with influenza A2 virus infection. Ann Intern Med 76 (1972) 91-94
42. Rohde G., Wiethege A., Borg I., et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58 (2003) 37-42
43. Lin C.Y., Kuo Y.C., Liu W.T., and Lin C.C. Immunomodulation of influenza virus infection in the precipitating asthma attack. Chest 93 (1988) 1234-1238
44. Foulkes W., Rees J., and Sewry C. Influenza A and rhabdomyolysis. J Infect 21 (1990) 303-304
45. Studahl M. Influenza virus and CNS manifestations. J Clin Virol 28 (2003) 225-232
46. Hurwitz E.S., Nelson D.B., Davis C., et al. National surveillance for Reye syndrome: a five-year review. Pediatrics 70 (1982) 895-900
47. Barr C.E., Mednick S.A., and Munk-Jorgensen P. Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study. Arch Gen Psychiatry 47 (1990) 869-874
48. Ison M.G., Campbell V., Rembold C., et al. Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clin Infect Dis 40 (2005) 415-422
49. Jefferson T.O., Rivetti D., Di Pietrantonj C., et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev (2007) CD001269
50. Rivetti D., Jefferson T., Thomas R., et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 3 (2006) CD004876
51. Castle S.C. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 31 (2000) 578-585
52. Kang I., Hong M.S., Nolasco H., et al. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 173 (2004) 673-681
53. Jefferson T. Influenza vaccination: policy versus evidence. BMJ 333 (2006) 912-915
54. Jackson L.A., Jackson M.L., Nelson J.C., et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35 (2006) 337-344
55. Mangtani P., Cumberland P., Hodgson C.R., et al. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 190 (2004) 1-10
56. Jackson L.A., Nelson J.C., Benson P., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 35 (2006) 345-352
57. Simonsen L., Viboud C., Blackwelder W.C., et al. Researchers defend influenza vaccine study. Infectious Disease News (2005)
58. Wilde J.A., McMillan J.A., Serwint J., et al. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 281 (1999) 908-913
59. Elder A.G., O'Donnell B., McCruden E.A., et al. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire. BMJ 313 (1996) 1241-1242
60. Potter J., Stott D.J., Roberts M.A., et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 175 (1997) 1-6
61. Carman W.F., Elder A.G., Wallace L.A., et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 355 (2000) 93-97
62. Bright R.A., Shay D.K., Shu B., et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295 (2006) 891-894
63. Kiso M., Mitamura K., Sakai-Tagawa Y., et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364 (2004) 759-765
64. Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons. Wkly Epidemiol Rec 82 (2007) 149-150
65. Beigel J.H., Farrar J., Han A.M., et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 353 (2005) 1374-1385
66. Whitley R.J., Hayden F.G., Reisinger K.S., et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 20 (2001) 127-133
67. Treanor J.J., Hayden F.G., Vrooman P.S., et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 283 (2000) 1016-1024
68. Monto A.S., Webster A., and Keene O. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis. J Antimicrob Chemother 44 Suppl B (1999) 23-29
69. Jefferson T., Deeks J.J., Demicheli V., et al. Amantadine and rimantadine for preventing and treating influenza A in adults. Cochrane Database Syst Rev (2004) CD001169
70. Aoki F.Y., Macleod M.D., Paggiaro P., et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J. Antimicrob Chemother 51 (2003) 123-129
71. Lalezari J., Campion K., Keene O., and Silagy C. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials. Arch Intern Med 161 (2001) 212-217
72. Kaiser L., Wat C., Mills T., et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 163 (2003) 1667-1672
73. de Jong M.D., Thanh T.T., Khanh T.H., et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353 (2005) 2667-2672
74. Govorkova E.A., Ilyushina N.A., Boltz D.A., et al. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother 51 (2007) 1414-1424
75. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 Suppl 2 (2007) S27-S72
76. Coles F.B., Balzano G.J., and Morse D.L. An outbreak of influenza A (H3N2) in a well immunized nursing home population. J Am Geriatr Soc 40 (1992) 589-592
77. Drinka P.J., Gravenstein S., Krause P., et al. Outbreaks of influenza A and B in a highly immunized nursing home population. J Fam Pract 45 (1997) 509-514
78. Arden N.H., Patriarca P.A., Fasano M.B., et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 148 (1988) 865-868
79. Dolin R., Reichman R.C., Madore H.P., et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 307 (1982) 580-584
80. Peters Jr. P.H., Gravenstein S., Norwood P., et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 49 (2001) 1025-1031
81. Schilling M., Povinelli L., Krause P., et al. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Vaccine 16 (1998) 1771-1774
82. Gravenstein S., Drinka P., Osterweil D., et al. Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population. J Am Med Dir Assoc 6 (2005) 359-366
83. Mancini G.B., Etminan M., Zhang B., et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 47 (2006) 2554-2560
84. Schlienger R.G., Fedson D.S., Jick S.S., et al. Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy 27 (2007) 325-332
85. Mortensen E.M., Restrepo M.I., Anzueto A., and Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res 6 (2005) 82
86. Majumdar S.R., McAlister F.A., Eurich D.T., et al. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 333 (2006) 999 Epub 2006 Oct 23
87. Fedson D.S. Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis 43 (2006) 199-205